Patents by Inventor Bjorn Eek

Bjorn Eek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CONNECTIVE TISSUE INJURIES
    Publication number: 20260069659
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ? 2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Application
    Filed: November 13, 2025
    Publication date: March 12, 2026
    Inventor: Bjorn Eek
  • Treatment of connective tissue injuries
    Patent number: 12472234
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ?2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: November 18, 2025
    Inventor: Bjorn Eek
  • TREATMENT OF CONNECTIVE TISSUE INJURIES
    Publication number: 20250222071
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ? 2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Application
    Filed: September 24, 2024
    Publication date: July 10, 2025
    Inventor: Bjorn Eek
  • TREATMENT OF INTERNAL DISC DISRUPTION AND CONNECTIVE TISSUE INJURIES
    Publication number: 20250213653
    Abstract: This disclosure relates to treating internal disc disruption or a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) or transforming growth factor beta 2 (TGF-?2), fibroblast growth factor (FGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Application
    Filed: October 16, 2024
    Publication date: July 3, 2025
    Inventor: Bjorn Eek
  • Treatment of internal disc disruption and connective tissue injuries
    Patent number: 12144844
    Abstract: This disclosure relates to treating internal disc disruption or a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) or transforming growth factor beta 2 (TGF-?2), fibroblast growth factor (FGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: November 19, 2024
    Inventor: Bjorn Eek
  • Treatment of connective tissue injuries
    Patent number: 12128088
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ?2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Grant
    Filed: September 20, 2023
    Date of Patent: October 29, 2024
    Inventor: Bjorn Eek
  • TREATMENT OF CONNECTIVE TISSUE INJURIES
    Publication number: 20240009273
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ?2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Application
    Filed: September 20, 2023
    Publication date: January 11, 2024
    Inventor: Bjorn Eek
  • TREATMENT OF CONNECTIVE TISSUE INJURIES
    Publication number: 20230082005
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ? 2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Application
    Filed: March 2, 2022
    Publication date: March 16, 2023
    Inventor: Bjorn Eek
  • TREATMENT OF INTERNAL DISC DISRUPTION AND CONNECTIVE TISSUE INJURIES
    Publication number: 20230066890
    Abstract: This disclosure relates to treating internal disc disruption or a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) or transforming growth factor beta 2 (TGF-?2), fibroblast growth factor (FGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Application
    Filed: March 29, 2022
    Publication date: March 2, 2023
    Inventor: Bjorn Eek
  • Treatment of internal disc disruption and connective tissue injuries
    Patent number: 11318187
    Abstract: This disclosure relates to treating internal disc disruption or a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) or transforming growth factor beta 2 (TGF-?2), fibroblast growth factor (FGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: May 3, 2022
    Inventor: Bjorn Eek
  • Treatment of connective tissue injuries
    Patent number: 11298406
    Abstract: This disclosure relates to treating a connective tissue injury. The treatment involves injecting, or otherwise administering, a therapeutic composition into an animal, such as a human being, in need thereof. The therapeutic composition may contain transforming growth factor beta 1 (TGF-?1) and/or transforming growth factor ? 2 (TGF-?2), connective tissue growth factor (CTGF), and a pharmaceutically acceptable excipient or a secondary agent.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: April 12, 2022
    Inventor: Bjorn Eek
  • Method and pharmaceutical to treat spinal discs
    Publication number: 20050282774
    Abstract: An injectable for injection into a spinal disc, and a method to treat a spinal disc with the injectable. The injectable consists essentially of chondroitin sulfate and glucosamine HCl buffered to a pH above about 6.0.
    Type: Application
    Filed: August 24, 2005
    Publication date: December 22, 2005
    Inventor: Bjorn Eek